查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1655343

全球瘧疾診斷市場

Malaria Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 162 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球瘧疾診斷市場規模將達 13 億美元

2024 年全球瘧疾診斷市場規模估計為 9.017 億美元，預計 2030 年將達到 13 億美元，2024-2030 年分析期間的複合年成長率為 5.6%。快速診斷測試是報告中分析的細分市場之一，預計到分析期結束時複合年成長率為 5.7%，達到 6.859 億美元。在分析期內，顯微鏡診斷部分預計將以 4.9% 的複合年成長率成長。

美國市場規模估計為 2.333 億美元，中國市場預計複合年成長率為 8.6%

預計 2024 年美國瘧疾診斷市場價值將達到 2.333 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 2.9 億美元，2024-2030 年分析期間的複合年成長率為 8.6%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 3.3% 和 4.5%。在歐洲，德國的複合年成長率預計為 4.2%。

全球瘧疾診斷市場 - 主要趨勢與促進因素摘要

在對抗這種地方性疾病的過程中，瘧疾診斷技術有何發展？

瘧疾診斷對於全球對抗最受歡迎的寄生蟲疾病至關重要，特別是在撒哈拉以南非洲和東南亞等地區。準確、早期發現瘧疾對於有效治療瘧疾、防止嚴重併發症和死亡至關重要。顯微鏡和快速診斷測試（RDT）等傳統診斷方法長期以來一直是瘧疾診斷的黃金標準。然而，診斷技術的進步正在提高這些測試的準確性、速度和可用性。聚合酵素鏈鎖反應（PCR）測試等新的分子診斷工具提高了靈敏度，可以檢測到傳統方法可能遺漏的低水平寄生蟲。診斷技術的進步對於繼續全球消除瘧疾和改善患者治療效果的努力至關重要。

哪些技術創新正在改變瘧疾診斷？

技術創新在瘧疾診斷方面取得了巨大進步，提高了其準確性和可近性。最顯著的進展之一是可攜式分子檢測設備的引入，它可以在偏遠和資源有限的環境中進行高度準確的檢測。利用環介導等恒溫環型核酸擴增(LAMP) 等技術，這些測試可以提供快速的結果，而無需大規模的測試基礎設施。此外，數位顯微鏡的進步可以自動檢測寄生蟲，減少人為錯誤並提高診斷工作流程的效率。人工智慧和機器學習在診斷中的應用進一步改善了對測試結果的解釋，使臨床醫生能夠就瘧疾治療做出更快、更可靠的決策。

在資源有限的地區，瘧疾診斷面臨哪些挑戰？

儘管瘧疾診斷技術取得了進展，但在資源有限的地區部署這些工具仍面臨挑戰。一個主要問題是先進診斷技術的成本和複雜性，這可能會限制其在瘧疾最流行的偏遠地區的使用。顯微鏡和 RDT 等傳統方法雖然具有成本效益，但需要熟練的人員，並且仍可能錯過低水平感染。另一個挑戰是在疫情爆發期間維持診斷材料的供應鏈並確保難以到達的地區能夠進行檢測。此外，不同地區的診斷品質存在差異，培訓和設備也不一致，阻礙了實現普遍獲得可靠的瘧疾診斷的努力。消除這些障礙對於改善瘧疾控制並最終減輕流行地區的疾病負擔至關重要。

瘧疾診斷市場的成長將受到多種因素的推動

瘧疾診斷市場的成長受到多種因素的推動，包括流行地區瘧疾盛行率的增加、診斷技術的進步以及全球消除瘧疾的努力。攜帶式分子診斷和人工智慧工具等技術創新正在擴大準確和及時診斷的機會，即使在醫療保健基礎設施有限的地區也是如此。政府和非政府組織為消除瘧疾而增加的資金也加速了改進診斷方法的採用。此外，人們越來越意識到早期檢測對於預防瘧疾導致的嚴重疾病和死亡的重要性，這也推動了對更可靠、更有效的檢測解決方案的需求。這些因素加上正在進行的研究和開發努力，預計將推動瘧疾診斷市場的持續成長。

部分

細分領域（快速診斷測試、顯微鏡檢查、分子診斷）

受訪公司範例（16家值得關注的公司）

  • 1-800MD
  • Access Bio, Inc.
  • AlphaHelix Technologies AB
  • AmeriPath, Inc.
  • Apollo Diagnostics
  • Biocan Diagnostics
  • Biohelix
  • bioMerieux Sweden AB
  • Bioperfectus Technologies
  • Biotype Diagnostics

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP13150

Global Malaria Diagnostics Market to Reach US$1.3 Billion by 2030

The global market for Malaria Diagnostics estimated at US$901.7 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Rapid Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$685.9 Million by the end of the analysis period. Growth in the Microscopic Diagnostics segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$233.3 Million While China is Forecast to Grow at 8.6% CAGR

The Malaria Diagnostics market in the U.S. is estimated at US$233.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$290.0 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Malaria Diagnostics Market - Key Trends & Drivers Summarized

How Are Malaria Diagnostics Evolving in the Fight Against This Endemic Disease?

Malaria diagnostics are crucial in the global fight against one of the most prevalent parasitic diseases, particularly in regions like sub-Saharan Africa and Southeast Asia. Accurate and early detection of malaria is essential to effectively treating the disease and preventing severe complications or death. Traditional diagnostic methods like microscopy and rapid diagnostic tests (RDTs) have long been the gold standard in malaria diagnosis. However, advances in diagnostic technologies are improving the accuracy, speed, and accessibility of these tests. New molecular diagnostic tools, such as polymerase chain reaction (PCR) testing, have enhanced sensitivity and can detect low parasite levels that are often missed by conventional methods. The evolution of diagnostic techniques is vital in the ongoing global efforts to eliminate malaria and improve patient outcomes.

What Technological Innovations Are Transforming Malaria Diagnostics?

Technological innovations are driving significant advancements in malaria diagnostics, improving their accuracy and accessibility. One of the most notable developments is the introduction of portable molecular testing devices, which allow for highly accurate detection in remote or resource-limited settings. These devices, which use techniques like loop-mediated isothermal amplification (LAMP), can provide results quickly without requiring extensive laboratory infrastructure. Additionally, advancements in digital microscopy have enabled automated parasite detection, reducing human error and increasing the efficiency of diagnostic workflows. The integration of AI and machine learning in diagnostics has further improved the interpretation of test results, helping clinicians make faster and more reliable decisions regarding malaria treatment.

What Are the Challenges Facing Malaria Diagnostics in Resource-Limited Areas?

Despite the progress in malaria diagnostics, there are several challenges in deploying these tools in resource-limited areas. One major issue is the cost and complexity of advanced diagnostic methods, which can limit their availability in remote regions where malaria is most prevalent. Traditional methods like microscopy and RDTs, while cost-effective, require skilled personnel and can still miss low-level infections. Another challenge is maintaining the supply chain for diagnostic materials and ensuring that tests are available in hard-to-reach areas during outbreaks. Additionally, the variability in diagnostic quality across regions, driven by inconsistent training and equipment, hinders efforts to achieve universal access to reliable malaria diagnostics. Addressing these barriers is critical for improving malaria management and ultimately reducing the disease burden in endemic areas.

Growth in the Malaria Diagnostics Market Is Driven by Several Factors

The growth in the malaria diagnostics market is driven by several factors, including the increasing prevalence of malaria in endemic regions, advancements in diagnostic technologies, and global efforts toward malaria elimination. Technological innovations such as portable molecular diagnostics and AI-driven tools are expanding access to accurate and timely diagnostics in areas with limited healthcare infrastructure. The rise in funding from governmental and non-governmental organizations aimed at combating malaria is also accelerating the adoption of improved diagnostic methods. Furthermore, the growing awareness of the importance of early detection in preventing severe malaria cases and fatalities is pushing demand for more reliable and efficient testing solutions. These factors, combined with ongoing R&D efforts, are expected to drive continued growth in the malaria diagnostics market.

SCOPE OF STUDY:

The report analyzes the Malaria Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Rapid Diagnostic Tests, Microscopic Diagnostics, Molecular Diagnostics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 16 Featured) -

  • 1-800MD
  • Access Bio, Inc.
  • AlphaHelix Technologies AB
  • AmeriPath, Inc.
  • Apollo Diagnostics
  • Biocan Diagnostics
  • Biohelix
  • bioMerieux Sweden AB
  • Bioperfectus Technologies
  • Biotype Diagnostics

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Malaria Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Malaria Drives Growth in Malaria Diagnostics Market
    • Technological Advancements in Rapid Diagnostic Tests Propel Adoption in Malaria-endemic Regions
    • Increased Focus on Early Detection Strengthens Business Case for Advanced Diagnostic Solutions
    • Emergence of Point-of-care Diagnostics Spurs Growth in Remote and Low-resource Settings
    • Rising Availability of Multiplex Diagnostic Platforms Propels Adoption of Comprehensive Testing
    • Increasing Global Health Initiatives to Combat Malaria Expand Market for Diagnostic Tools
    • Advancements in Molecular Diagnostics Strengthen Business Case for Accurate Malaria Detection
    • Rising Need for Accurate Surveillance Tools Accelerates Demand for Innovative Diagnostics
    • Growing Focus on Precision Medicine Generates Demand for Genotype-specific Malaria Diagnostics
    • Improved Diagnostic Technologies Propel Growth in Drug Resistance Testing for Malaria
    • Increasing Prevalence of Multi-drug-resistant Malaria Strains Drives Need for Advanced Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Malaria Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Malaria Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Rapid Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Rapid Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Rapid Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Microscopic Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Microscopic Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Microscopic Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • JAPAN
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • CHINA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • EUROPE
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Malaria Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • FRANCE
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • GERMANY
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Malaria Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • INDIA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Malaria Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Malaria Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • AFRICA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030

IV. COMPETITION